{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:33:36Z","timestamp":1791959616491,"version":"4.3.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,1,21]],"date-time":"2013-01-21T00:00:00Z","timestamp":1358726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,1,21]],"date-time":"2013-01-21T00:00:00Z","timestamp":1358726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1038\/bmt.2012.277","type":"journal-article","created":{"date-parts":[[2013,1,21]],"date-time":"2013-01-21T12:04:52Z","timestamp":1358769892000},"page":"1008-1009","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Yellow fever vaccine viremia following ablative BM suppression in AML"],"prefix":"10.1038","volume":"48","author":[{"given":"V I","family":"Avelino-Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F E","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E C","family":"Sabino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A S","family":"Nishiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"da Silva Freire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Blumm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C A","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y S","family":"Novis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E G","family":"Kallas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,21]]},"reference":[{"key":"BFbmt2012277_CR1","doi-asserted-by":"publisher","first-page":"6077","DOI":"10.1016\/j.vaccine.2008.09.009","volume":"26","author":"NP Lindsey","year":"2008","unstructured":"Lindsey NP, Schroeder BA, Miller ER, Braun MM, Hinckley AF, Marano N et al. Adverse event reports following yellow fever vaccination. Vaccine 2008; 26: 6077\u20136082.","journal-title":"Vaccine"},{"key":"BFbmt2012277_CR2","first-page":"131","volume":"85","author":"K Kengsakul","year":"2002","unstructured":"Kengsakul K, Sathirapongsasuti K, Punyagupta S . Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection. J Med Assoc Thai 2002; 85: 131\u2013134.","journal-title":"J Med Assoc Thai"},{"key":"BFbmt2012277_CR3","first-page":"32","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","unstructured":"Centers for Disease Control and Prevention. Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2010; 59: 32.","journal-title":"MMWR"},{"key":"BFbmt2012277_CR4","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1086\/605430","volume":"49","author":"LK Pickering","year":"2009","unstructured":"Pickering LK, Baker CJ, Freed GL, Gall SA, Grogg SE, Poland GA et al. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49: 817\u2013840.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2012277_CR5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1600-0609.2004.00218.x","volume":"72","author":"R Gowda","year":"2004","unstructured":"Gowda R, Cartwright K, Bremner JA, Green ST . Yellow fever vaccine: a successful vaccination of an immunocompromised patient. Eur J Haematol 2004; 72: 299\u2013301.","journal-title":"Eur J Haematol"},{"key":"BFbmt2012277_CR6","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1708-8305.2009.00336.x","volume":"16","author":"JA Yax","year":"2009","unstructured":"Yax JA, Farnon EC, Cary Engleberg N . Successful immunization of an allogeneic bone marrow transplant recipient with live, attenuated yellow fever vaccine. J Travel Med 2009; 16: 365\u2013367.","journal-title":"J Travel Med"},{"key":"BFbmt2012277_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/(SICI)1096-9071(199810)56:2<159::AID-JMV10>3.0.CO;2-B","volume":"56","author":"B Reinhardt","year":"1998","unstructured":"Reinhardt B, Jaspert R, Niedrig M, Kostner C, L'Age-Stehr J . Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection. J Med Virol 1998; 56: 159\u2013167.","journal-title":"J Med Virol"},{"key":"BFbmt2012277_CR8","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1046\/j.1365-3156.1999.00496.x","volume":"4","author":"M Niedrig","year":"1999","unstructured":"Niedrig M, Lademann M, Emmerich P, Lafrenz M . Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA. Trop Med Int Health 1999; 4: 867\u2013871.","journal-title":"Trop Med Int Health"},{"key":"BFbmt2012277_CR9","doi-asserted-by":"publisher","first-page":"6327","DOI":"10.1016\/j.vaccine.2011.05.019","volume":"29","author":"JR Nascimento Silva","year":"2011","unstructured":"Nascimento Silva JR, Camacho LA, Siqueira MM, Siqueira MM, Freire Mde S, Castro YP et al. Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella. Vaccine 2011; 29: 6327\u20136334.","journal-title":"Vaccine"},{"key":"BFbmt2012277_CR10","unstructured":"National Institute for Biological Standards and Control. WHO reference reagent. The 1st international reference preparation for anti-yellow fever serum monkey. Available from http:\/\/www.nibsc.ac.uk\/documents\/ifu\/YF.pdf, 2008 (accessed March 15, 2011."},{"key":"BFbmt2012277_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jviromet.2008.03.026","volume":"151","author":"N Mantel","year":"2008","unstructured":"Mantel N, Aguirre M, Gulia S, Girerd-Chambaz Y, Colombani S, Moste C et al. Standardized quantitative RT-PCR assays for quantitation of yellow fever and chimeric yellow fever-dengue vaccines. J Virol Methods 2008; 151: 40\u201346.","journal-title":"J Virol Methods"},{"key":"BFbmt2012277_CR12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.4269\/ajtmh.2012.11-0525","volume":"86","author":"RE Thomas","year":"2012","unstructured":"Thomas RE, Lorenzetti DL, Spragins W, Jackson D, Williamson T . The safety of yellow fever vaccine 17D or 17DD in children, pregnant women, HIV+ individuals, and older persons: systematic review. Am J Trop Med Hyg 2012; 86: 359\u2013372.","journal-title":"Am J Trop Med Hyg"},{"key":"BFbmt2012277_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/S0140-6736(01)05327-2","volume":"358","author":"M Martin","year":"2001","unstructured":"Martin M, Tsai TF, Cropp B, Chang GJ, Holmes DA, Tseng J et al. Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases. Lancet 2001; 358: 98\u2013104.","journal-title":"Lancet"},{"key":"BFbmt2012277_CR14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1006\/viro.2001.1168","volume":"290","author":"R Galler","year":"2001","unstructured":"Galler R, Pugachev KV, Santos CL, Ocran SW, Jabor AV, Rodrigues SG et al. Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil. Virology 2001; 290: 309\u2013319.","journal-title":"Virology"},{"key":"BFbmt2012277_CR15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0140-6736(01)05341-7","volume":"358","author":"RC Chan","year":"2001","unstructured":"Chan RC, Penney DJ, Little D, Carter IW, Roberts JA, Rawlinson WD . Hepatitis and death following vaccination with 17D-204 yellow fever vaccine. Lancet 2001; 358: 121\u2013122.","journal-title":"Lancet"},{"key":"BFbmt2012277_CR16","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1016\/j.vaccine.2006.01.009","volume":"24","author":"AR Engel","year":"2006","unstructured":"Engel AR, Vasconcelos PF, McArthur MA, Barrett AD . Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil. Vaccine 2006; 24: 2803\u20132809.","journal-title":"Vaccine"},{"key":"BFbmt2012277_CR17","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1086\/587844","volume":"197","author":"HG Bae","year":"2008","unstructured":"Bae HG, Domingo C, Tenorio A, de Ory F, Mu\u00f1oz J, Weber P et al. Immune response during adverse events after 17D-derived yellow fever vaccination in Europe. J Infect Dis 2008; 197: 1577\u20131584.","journal-title":"J Infect Dis"},{"key":"BFbmt2012277_CR18","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1086\/590187","volume":"198","author":"B Pulendran","year":"2008","unstructured":"Pulendran B, Miller J, Querec TD, Akondy R, Moseley N, Laur O et al. Case of yellow fever vaccine-associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes. J Infect Dis 2008; 198: 500\u2013507.","journal-title":"J Infect Dis"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2012277.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2012277","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2012277.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T16:11:00Z","timestamp":1648051860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2012277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,21]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["BFbmt2012277"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2012.277","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,21]]},"assertion":[{"value":"21 January 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}